Celldex Therapeutics reported $1.65B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Agenus USD 204M 164M Jun/2025
Amgen USD 201.45B 25.2B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Celldex Therapeutics USD 1.72B 367M Sep/2025
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Nektar Therapeutics USD 113M 4M Sep/2023
Northwest Biotherapeutics USD 1.02B 403M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
Rigel Pharmaceuticals USD 188M 36M Sep/2023
Roche Holding CHF 266.34B 55.46B Dec/2025